• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antineoplastic drugs in 1990. A review (Part II).

作者信息

Black D J, Livingston R B

机构信息

School of Pharmacy Service, University of Washington, Seattle.

出版信息

Drugs. 1990 May;39(5):652-73. doi: 10.2165/00003495-199039050-00003.

DOI:10.2165/00003495-199039050-00003
PMID:2191847
Abstract
摘要

相似文献

1
Antineoplastic drugs in 1990. A review (Part II).1990年的抗肿瘤药物。综述（第二部分）。
Drugs. 1990 May;39(5):652-73. doi: 10.2165/00003495-199039050-00003.
2
Cancer chemotherapeutic agents.癌症化疗药物。
Tex Med. 1977 May;73(5):57-67.
3
The clinical pharmacology and use of antineoplastic drugs.抗肿瘤药物的临床药理学与应用
J Tenn Med Assoc. 1979 Jan;72(1):23-33.
4
[The oncobiogram-- an indicator of chemotherapy in solid malignant human tumors].[肿瘤生物图谱——人类实体恶性肿瘤化疗的一个指标]
Zentralbl Chir. 1974 Sep 20;99(38):1198-208.
5
Antineoplastic chemotherapy.
South Med J. 1977 Jul;70(7):847-54. doi: 10.1097/00007611-197707000-00025.
6
Anticancer chemotherapy.抗癌化疗
Br Med J (Clin Res Ed). 1983 Jul 9;287(6385):110-3. doi: 10.1136/bmj.287.6385.110.
7
Chemotherapy in gynecological malignancies--and its nursing aspects.妇科恶性肿瘤的化疗及其护理要点
JOGN Nurs. 1976 Sep-Oct;5(5):9-14. doi: 10.1111/j.1552-6909.1976.tb02331.x.
8
Chemotherapy of solid tumors.实体瘤的化疗
Aktuelle Probl Chir. 1970;14:807-34.
9
Antitumor antibiotics, epipodophyllotoxins, and vinca alkaloids: clinical developments.
Curr Opin Oncol. 1990 Dec;2(6):1115-8. doi: 10.1097/00001622-199012000-00015.
10
Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.在依托泊苷和顺铂作用下筛选出的人小细胞肺癌细胞系的耐药机制
Cancer. 1996 May 1;77(9):1797-808. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1797::AID-CNCR7>3.0.CO;2-9.

引用本文的文献

1
Doxorubicin cardiotoxicity: prevention of congestive heart failure with serial cardiac function monitoring with equilibrium radionuclide angiocardiography in the current era.阿霉素心脏毒性：在当代通过平衡放射性核素心血管造影术进行系列心脏功能监测来预防充血性心力衰竭。
J Nucl Cardiol. 2003 Mar-Apr;10(2):132-9. doi: 10.1067/mnc.2003.7.
2
Cardiotoxicity of doxorubicin and other anthracycline derivatives.阿霉素及其他蒽环类衍生物的心脏毒性
J Nucl Cardiol. 2000 Jan-Feb;7(1):53-62. doi: 10.1067/mnc.2000.103324.
3
Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugs.

本文引用的文献

1
Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid.叶酸拮抗剂4-氨基蝶酰谷氨酸诱导儿童急性白血病的暂时缓解。
N Engl J Med. 1948 Jun 3;238(23):787-93. doi: 10.1056/NEJM194806032382301.
2
Subcutaneous fat necrosis with acute hemorrhagic pancreatitis-a case in a child with steroid-resistant nephrosis treated with 6-mercaptopurine.皮下脂肪坏死合并急性出血性胰腺炎——1例接受6-巯基嘌呤治疗的激素抵抗型肾病患儿病例
Calif Med. 1967 Jan;106(1):58-63.
3
COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. I.
对医护人员有害的药物。监测细胞毒性药物职业暴露方法的评估。
Drug Saf. 1999 Apr;20(4):347-59. doi: 10.2165/00002018-199920040-00004.
4
Clinical relevance of radionuclide angiography and antimyosin immunoscintigraphy for risk assessment in epirubicin cardiotoxicity.放射性核素血管造影和抗肌球蛋白免疫闪烁成像在表柔比星心脏毒性风险评估中的临床相关性。
J Nucl Cardiol. 1997 Nov-Dec;4(6):502-8. doi: 10.1016/s1071-3581(97)90008-8.
5
Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum.细胞周期蛋白D1反义核酸对基础状态及有丝分裂原刺激的胰腺癌细胞生长的抑制作用，与致瘤性丧失及对顺铂细胞毒性的增强有关。
J Clin Invest. 1998 Jan 15;101(2):344-52. doi: 10.1172/JCI1323.
6
Mitoxantrone induces nonimmunological histamine release from rat mast cells.米托蒽醌诱导大鼠肥大细胞释放非免疫性组胺。
Inflamm Res. 1996 Mar;45(3):113-7. doi: 10.1007/BF02265162.
7
Cancer risk assessment for health care workers occupationally exposed to cyclophosphamide.职业接触环磷酰胺的医护人员的癌症风险评估。
Int Arch Occup Environ Health. 1995;67(5):317-23. doi: 10.1007/BF00385647.
Cancer Chemother Rep. 1965 Jan;18:SUPPL 2:1-401.
4
THE STATHMOKINETIC EFFECT OF VINCRISTIME.长春新碱的有丝分裂抑制效应。
Cancer Res. 1964 Dec;24:1918-25.
5
HEPATOTOXICITY OF MERCAPTOPURINE.巯嘌呤的肝毒性
JAMA. 1964 Jun 1;188:802-6. doi: 10.1001/jama.1964.03060350028007.
6
THE TUMOR-INHIBITORY EFFECTS OF THE METHYLHYDRAZINE DERIVATIVE RO 4-6467/1 (NSC-77213).
Cancer Chemother Rep. 1963 Dec;33:1-4.
7
THE MECHANISM OF ACTION OF ALKYLATING AGENTS.烷化剂的作用机制。
Cancer Res. 1963 Sep;23:1315-33.
8
THE BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ACTION AND EFFECTS OF THE FOLIC ACID ANTAGONISTS.叶酸拮抗剂的生化、细胞及药理作用与效应
Cancer Res. 1963 Sep;23:1277-85.
9
Studies on the diabetogenic action of streptozotocin (NSC-37917).链脲佐菌素（NSC - 37917）致糖尿病作用的研究。
Cancer Chemother Rep. 1963 May;29:91-8.
10
The degradation of deoxyribonucleic acid by new tumour inhibiting compounds: the intermediate formation of hydrogen peroxide.
Experientia. 1963 Mar 15;19:132-3. doi: 10.1007/BF02171591.